| 0.6 |
2.4 |
GO:2000768 |
positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.6 |
2.9 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.6 |
1.7 |
GO:0033214 |
iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 0.5 |
1.6 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.4 |
1.2 |
GO:0034059 |
response to anoxia(GO:0034059) |
| 0.4 |
1.2 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.4 |
1.1 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.3 |
1.0 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.3 |
1.6 |
GO:0072313 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.3 |
0.9 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.3 |
0.9 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.3 |
0.9 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.3 |
0.9 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.3 |
2.0 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.3 |
0.9 |
GO:0072229 |
proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 0.3 |
6.0 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.3 |
0.8 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 0.3 |
0.8 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.3 |
0.5 |
GO:0003064 |
regulation of heart rate by hormone(GO:0003064) |
| 0.3 |
0.8 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.3 |
1.0 |
GO:0003331 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.2 |
1.0 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.2 |
8.6 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.2 |
0.7 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.2 |
1.8 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.2 |
0.5 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.2 |
0.7 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.2 |
0.9 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 |
0.8 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.2 |
0.2 |
GO:2001190 |
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.2 |
0.6 |
GO:1904397 |
negative regulation of neuromuscular junction development(GO:1904397) |
| 0.2 |
0.6 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.2 |
0.6 |
GO:0061054 |
dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 0.2 |
1.5 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.2 |
0.9 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.2 |
1.3 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.2 |
1.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
0.2 |
GO:0072186 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 0.2 |
1.0 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.2 |
0.5 |
GO:0021524 |
visceral motor neuron differentiation(GO:0021524) |
| 0.2 |
0.2 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 |
0.7 |
GO:0002503 |
peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 |
3.7 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.2 |
0.6 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 |
0.6 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 |
0.6 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.2 |
0.6 |
GO:0001545 |
primary ovarian follicle growth(GO:0001545) |
| 0.1 |
0.4 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.1 |
0.7 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.6 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.1 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
2.0 |
GO:0019614 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.1 |
0.4 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.1 |
1.5 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.1 |
0.7 |
GO:0006475 |
internal protein amino acid acetylation(GO:0006475) |
| 0.1 |
2.4 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.9 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
1.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.8 |
GO:0046098 |
guanine metabolic process(GO:0046098) |
| 0.1 |
0.5 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.4 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.1 |
0.7 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.4 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 |
0.4 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.5 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
1.0 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.1 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
0.2 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 |
0.4 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.5 |
GO:0036378 |
calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.1 |
0.3 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.1 |
0.2 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.1 |
0.2 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 |
0.6 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.1 |
0.6 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.2 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 |
1.1 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.1 |
1.9 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.1 |
0.7 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.1 |
0.4 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.1 |
0.1 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.1 |
0.3 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.1 |
0.4 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 |
0.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.3 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.1 |
GO:0002125 |
maternal aggressive behavior(GO:0002125) |
| 0.1 |
0.1 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.1 |
0.5 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.1 |
0.3 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.3 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 |
0.4 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.1 |
0.1 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.1 |
1.8 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 |
0.7 |
GO:0060480 |
lung goblet cell differentiation(GO:0060480) |
| 0.1 |
0.4 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 |
1.0 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
0.9 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.4 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
0.4 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.1 |
0.3 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.1 |
0.1 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.5 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.5 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.1 |
0.3 |
GO:0015817 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.1 |
0.6 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.1 |
0.4 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.1 |
1.2 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.1 |
0.6 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.1 |
0.1 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.1 |
0.4 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) protein localization to ciliary membrane(GO:1903441) |
| 0.1 |
0.1 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.1 |
0.3 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.1 |
0.4 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 0.1 |
0.1 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.3 |
GO:0098937 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.1 |
1.0 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.1 |
0.4 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.1 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 |
0.3 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 0.1 |
0.6 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.1 |
0.3 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.1 |
0.3 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 |
0.5 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.1 |
1.8 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 |
0.8 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.1 |
0.1 |
GO:0050666 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.1 |
0.4 |
GO:1904764 |
negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.1 |
0.3 |
GO:0003402 |
planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.1 |
0.6 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
0.2 |
GO:2000866 |
positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.1 |
0.6 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.6 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.1 |
0.4 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.1 |
0.1 |
GO:0021730 |
trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
| 0.1 |
0.2 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 |
0.2 |
GO:0003104 |
positive regulation of glomerular filtration(GO:0003104) |
| 0.1 |
0.5 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.1 |
0.2 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.1 |
0.9 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.1 |
0.4 |
GO:0071504 |
cellular response to heparin(GO:0071504) |
| 0.1 |
0.4 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.1 |
0.1 |
GO:0072061 |
collecting duct development(GO:0072044) inner medullary collecting duct development(GO:0072061) |
| 0.1 |
0.1 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.1 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.1 |
0.2 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 |
0.2 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.1 |
6.0 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.1 |
0.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.7 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 |
0.3 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.1 |
0.7 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.1 |
0.2 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 |
0.2 |
GO:1903626 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.1 |
0.1 |
GO:0042160 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.1 |
0.1 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 |
0.2 |
GO:2000078 |
positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.1 |
0.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.2 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.1 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.1 |
0.4 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
0.1 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 |
0.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) spindle assembly involved in meiosis(GO:0090306) |
| 0.1 |
0.6 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
1.4 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
1.0 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.1 |
0.1 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 |
0.2 |
GO:0035915 |
pore formation in membrane of other organism(GO:0035915) |
| 0.1 |
0.1 |
GO:0071879 |
positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.1 |
0.1 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
0.9 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.1 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 0.1 |
0.2 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 |
0.8 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
1.1 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
0.1 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.1 |
0.5 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.1 |
0.5 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 |
0.8 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.1 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
0.6 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 |
1.1 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.1 |
0.7 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.1 |
0.1 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.2 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.1 |
0.4 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.4 |
GO:0060071 |
Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.1 |
0.2 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.1 |
0.2 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 |
0.2 |
GO:1902523 |
positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.1 |
0.4 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.9 |
GO:0031272 |
regulation of pseudopodium assembly(GO:0031272) |
| 0.1 |
0.1 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.1 |
0.1 |
GO:0045588 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) |
| 0.1 |
0.2 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.1 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 |
0.2 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.1 |
0.2 |
GO:0036343 |
psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.1 |
1.0 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 |
0.3 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.1 |
0.2 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.2 |
GO:1901899 |
positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 0.1 |
0.1 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 |
0.2 |
GO:0034239 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.1 |
0.4 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.1 |
0.2 |
GO:0044278 |
cell wall disruption in other organism(GO:0044278) |
| 0.1 |
0.1 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) dTTP metabolic process(GO:0046075) |
| 0.1 |
0.1 |
GO:1902869 |
regulation of amacrine cell differentiation(GO:1902869) |
| 0.1 |
0.2 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.2 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
0.2 |
GO:0072156 |
distal tubule morphogenesis(GO:0072156) |
| 0.1 |
0.3 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.1 |
0.2 |
GO:0033385 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 |
0.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.2 |
GO:1904048 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.1 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
0.5 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.1 |
GO:0051152 |
regulation of smooth muscle cell differentiation(GO:0051150) positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.1 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.1 |
0.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.1 |
0.2 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 |
0.4 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 |
0.1 |
GO:1901569 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 |
0.6 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.1 |
0.3 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.1 |
1.1 |
GO:0050908 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
0.2 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 |
0.3 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
1.9 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 |
0.5 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 |
0.8 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.4 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.2 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.1 |
0.2 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) regulation of oxygen metabolic process(GO:2000374) |
| 0.1 |
1.3 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.2 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.2 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.1 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
0.1 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.4 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.0 |
0.1 |
GO:1902996 |
regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.0 |
0.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
0.0 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 |
2.4 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.0 |
0.1 |
GO:0009436 |
glyoxylate catabolic process(GO:0009436) |
| 0.0 |
0.0 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.0 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.3 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.0 |
0.8 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.0 |
0.1 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.0 |
0.2 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.0 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.8 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
0.0 |
GO:2000791 |
mesenchymal cell proliferation involved in lung development(GO:0060916) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.0 |
0.1 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.0 |
0.1 |
GO:0003249 |
left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.0 |
0.1 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.0 |
0.4 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) |
| 0.0 |
0.1 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.0 |
0.5 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.0 |
0.0 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.0 |
0.1 |
GO:0046021 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.0 |
0.6 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.3 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.0 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.2 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.0 |
1.2 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.1 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.0 |
0.1 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 |
0.1 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.0 |
0.6 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.1 |
GO:0034699 |
response to luteinizing hormone(GO:0034699) |
| 0.0 |
0.3 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 0.0 |
0.1 |
GO:0051758 |
homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.0 |
0.3 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 0.0 |
0.6 |
GO:0071499 |
cellular response to laminar fluid shear stress(GO:0071499) |
| 0.0 |
2.2 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.0 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.0 |
0.2 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.1 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.0 |
0.1 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 |
0.1 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.0 |
0.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.0 |
0.6 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
1.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.0 |
0.2 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.0 |
0.2 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.0 |
0.1 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.0 |
GO:1903630 |
regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.0 |
0.0 |
GO:2000053 |
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.0 |
0.1 |
GO:0051311 |
meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.2 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.5 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.0 |
0.2 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.0 |
0.1 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.0 |
0.1 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.0 |
0.1 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.0 |
0.3 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.0 |
0.1 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.0 |
0.2 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.0 |
0.1 |
GO:0045726 |
positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.0 |
0.2 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.0 |
0.2 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.0 |
0.3 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.0 |
0.3 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.0 |
0.3 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.2 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.0 |
0.2 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.0 |
0.2 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.0 |
0.4 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 |
0.0 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.1 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.0 |
0.4 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.0 |
0.0 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.0 |
0.0 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.0 |
0.1 |
GO:0007439 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.0 |
0.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.0 |
0.2 |
GO:0021903 |
rostrocaudal neural tube patterning(GO:0021903) |
| 0.0 |
0.5 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.2 |
GO:0005985 |
sucrose metabolic process(GO:0005985) |
| 0.0 |
0.1 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.0 |
0.1 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.0 |
0.5 |
GO:0070070 |
proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 |
0.2 |
GO:0015853 |
adenine transport(GO:0015853) |
| 0.0 |
0.3 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.2 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.2 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.0 |
0.1 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 |
0.2 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.0 |
0.1 |
GO:0002101 |
tRNA wobble cytosine modification(GO:0002101) oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.0 |
1.0 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.0 |
0.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.3 |
GO:0002005 |
angiotensin catabolic process in blood(GO:0002005) |
| 0.0 |
0.2 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.0 |
0.3 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.0 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 |
0.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.0 |
0.7 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.1 |
GO:1904798 |
regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.0 |
0.1 |
GO:0009183 |
ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.0 |
0.3 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.0 |
0.4 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.0 |
0.0 |
GO:1903020 |
positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.0 |
0.0 |
GO:0071106 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.0 |
0.1 |
GO:0003176 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.0 |
0.1 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.0 |
0.2 |
GO:0046070 |
dGTP metabolic process(GO:0046070) |
| 0.0 |
0.1 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.0 |
0.2 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 |
0.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.0 |
0.0 |
GO:0021626 |
hindbrain maturation(GO:0021578) pons maturation(GO:0021586) central nervous system maturation(GO:0021626) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.0 |
0.0 |
GO:0035905 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.0 |
0.2 |
GO:1901090 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.0 |
0.2 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.4 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.0 |
0.1 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 0.0 |
0.2 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.0 |
0.4 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.2 |
GO:0086029 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.0 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.1 |
GO:1901185 |
negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.0 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 |
0.8 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.7 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.1 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.0 |
0.1 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.0 |
0.0 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.1 |
GO:1990441 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.0 |
0.8 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.0 |
0.1 |
GO:0009698 |
phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.0 |
0.0 |
GO:0003186 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) |
| 0.0 |
0.2 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.0 |
0.5 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.5 |
GO:0009128 |
purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.0 |
0.1 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.0 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.1 |
GO:0016260 |
selenocysteine biosynthetic process(GO:0016260) |
| 0.0 |
0.8 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 |
0.2 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
0.0 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 |
0.4 |
GO:0035372 |
protein localization to microtubule(GO:0035372) |
| 0.0 |
0.6 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.3 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.2 |
GO:0070294 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 |
0.0 |
GO:1903056 |
regulation of melanosome transport(GO:1902908) regulation of melanosome organization(GO:1903056) |
| 0.0 |
0.1 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.0 |
0.2 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.0 |
0.1 |
GO:0060492 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.0 |
0.3 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.0 |
0.1 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.0 |
0.3 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.0 |
0.1 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.0 |
0.0 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.5 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.1 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.0 |
0.3 |
GO:0060307 |
regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
| 0.0 |
0.2 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.0 |
0.3 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.0 |
0.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 |
1.9 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.3 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.2 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.0 |
0.6 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.0 |
0.2 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 |
0.2 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.0 |
0.1 |
GO:2000564 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.0 |
0.1 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.0 |
0.1 |
GO:0007497 |
posterior midgut development(GO:0007497) |
| 0.0 |
0.1 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.0 |
0.0 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 |
0.2 |
GO:0044146 |
negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.0 |
0.1 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.0 |
0.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.0 |
0.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.0 |
0.0 |
GO:1902514 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.0 |
0.2 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.0 |
0.1 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.0 |
0.0 |
GO:0055096 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.0 |
0.1 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.1 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 |
0.3 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.0 |
0.1 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.0 |
0.2 |
GO:0050879 |
multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.0 |
0.1 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.0 |
0.1 |
GO:0042489 |
negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.0 |
0.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.0 |
0.1 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.0 |
0.1 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.1 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.0 |
0.1 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.0 |
0.1 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.0 |
0.1 |
GO:0015842 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.0 |
0.1 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.0 |
0.0 |
GO:0061740 |
protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
| 0.0 |
0.2 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.1 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.0 |
0.8 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.0 |
GO:0032672 |
regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.0 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.9 |
GO:0035338 |
long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.1 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.0 |
0.1 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.0 |
0.0 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.0 |
0.1 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.0 |
0.3 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.0 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.3 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.0 |
0.2 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.2 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.0 |
0.2 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.0 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.0 |
0.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.0 |
0.2 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.0 |
0.2 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.0 |
0.5 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.7 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.0 |
0.1 |
GO:0072709 |
cellular response to sorbitol(GO:0072709) |
| 0.0 |
0.2 |
GO:0019317 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 |
0.2 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.0 |
0.2 |
GO:0036093 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.0 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.2 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.0 |
0.0 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.0 |
0.1 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.0 |
0.1 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.0 |
0.1 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.0 |
0.1 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.0 |
0.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.1 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.0 |
0.2 |
GO:0045959 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.0 |
0.1 |
GO:1901624 |
negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.0 |
0.1 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.0 |
0.0 |
GO:2000317 |
negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.0 |
0.3 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.1 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) negative regulation of neurotrophin production(GO:0032900) |
| 0.0 |
0.2 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.0 |
GO:0071231 |
cellular response to folic acid(GO:0071231) |
| 0.0 |
0.2 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 0.0 |
0.0 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.0 |
0.0 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 |
0.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 |
0.0 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.0 |
0.0 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0046885 |
regulation of hormone biosynthetic process(GO:0046885) |
| 0.0 |
0.3 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.0 |
0.3 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.6 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.1 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.0 |
0.2 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.5 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.0 |
0.0 |
GO:0071503 |
response to heparin(GO:0071503) |
| 0.0 |
0.5 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 |
0.0 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
1.1 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.0 |
0.1 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.0 |
0.0 |
GO:0051177 |
meiotic sister chromatid cohesion(GO:0051177) |
| 0.0 |
0.2 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.2 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.0 |
0.6 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.1 |
GO:0046010 |
positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.0 |
0.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.0 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.0 |
0.0 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
0.1 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
0.1 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.0 |
0.2 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.0 |
0.0 |
GO:0070431 |
nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.0 |
0.1 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.1 |
GO:0070839 |
divalent metal ion export(GO:0070839) |
| 0.0 |
0.2 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.0 |
0.1 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.1 |
GO:1903976 |
negative regulation of glial cell migration(GO:1903976) |
| 0.0 |
0.8 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.0 |
1.0 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.0 |
0.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.0 |
0.0 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.0 |
0.2 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.0 |
0.1 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.0 |
0.1 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.0 |
0.1 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 0.0 |
0.1 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.0 |
0.1 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.0 |
0.2 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.0 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.2 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.0 |
0.1 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.0 |
0.5 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:0070944 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.0 |
0.2 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.0 |
0.0 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.2 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.2 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.0 |
0.1 |
GO:0061358 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) |
| 0.0 |
0.1 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 0.0 |
0.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.1 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.0 |
0.0 |
GO:0034182 |
regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.0 |
0.1 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.0 |
0.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.0 |
0.1 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.4 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 |
0.1 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.0 |
0.2 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
0.1 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.0 |
0.2 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.1 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.0 |
0.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.0 |
0.0 |
GO:2000197 |
regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.0 |
0.0 |
GO:0061526 |
acetylcholine secretion(GO:0061526) |
| 0.0 |
0.4 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.0 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.1 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.0 |
0.1 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.1 |
GO:0015729 |
thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.0 |
0.1 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.4 |
GO:0010226 |
response to lithium ion(GO:0010226) |
| 0.0 |
0.1 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.0 |
0.0 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.0 |
0.1 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.0 |
0.1 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.0 |
0.0 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.0 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.0 |
0.2 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.1 |
GO:1904720 |
regulation of mRNA cleavage(GO:0031437) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) |
| 0.0 |
0.4 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
1.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.1 |
GO:0090212 |
regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.0 |
0.2 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.1 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.0 |
0.2 |
GO:1901898 |
negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.0 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.1 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.0 |
0.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.0 |
0.0 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.0 |
1.1 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.0 |
0.6 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 |
0.0 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 |
0.1 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.0 |
0.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.1 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.0 |
0.1 |
GO:0006424 |
glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.0 |
0.2 |
GO:2000484 |
positive regulation of interleukin-8 secretion(GO:2000484) |
| 0.0 |
0.1 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.1 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.0 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.0 |
GO:2001170 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.0 |
0.2 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 0.0 |
0.1 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.0 |
0.2 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 |
0.2 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.0 |
0.1 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.0 |
GO:1904683 |
regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metallopeptidase activity(GO:1905049) |
| 0.0 |
0.1 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.2 |
GO:2000651 |
positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 |
0.1 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.0 |
0.1 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.0 |
0.1 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.0 |
0.2 |
GO:0071545 |
inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
| 0.0 |
0.0 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.0 |
0.0 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.0 |
0.4 |
GO:0000717 |
nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.0 |
0.2 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.0 |
0.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) optic nerve structural organization(GO:0021633) |
| 0.0 |
0.1 |
GO:0099540 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.0 |
0.1 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.0 |
0.2 |
GO:0006836 |
neurotransmitter transport(GO:0006836) |
| 0.0 |
0.0 |
GO:0021997 |
neural plate axis specification(GO:0021997) |
| 0.0 |
0.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.4 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
0.0 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.0 |
0.1 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.0 |
0.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.0 |
0.9 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 |
0.1 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.0 |
0.1 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.0 |
0.1 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.0 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 |
0.0 |
GO:0034285 |
response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.0 |
0.1 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.0 |
0.1 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
1.4 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.0 |
0.1 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:0015846 |
polyamine transport(GO:0015846) |
| 0.0 |
0.1 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.0 |
0.0 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 0.0 |
0.1 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
0.1 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.2 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 |
0.1 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.5 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 |
0.1 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 |
0.3 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.1 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.0 |
0.1 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.1 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.0 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.1 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.2 |
GO:0034776 |
response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
| 0.0 |
0.1 |
GO:0034505 |
tooth mineralization(GO:0034505) |
| 0.0 |
0.2 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.0 |
0.1 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.1 |
GO:0002584 |
negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 0.0 |
0.0 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.0 |
0.1 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.0 |
0.1 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
| 0.0 |
0.1 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
1.2 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 |
0.3 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.0 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.0 |
0.0 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.0 |
0.1 |
GO:1904588 |
cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.0 |
0.4 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.0 |
0.0 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.0 |
0.1 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.0 |
0.1 |
GO:0032024 |
positive regulation of insulin secretion(GO:0032024) |
| 0.0 |
0.1 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.0 |
0.1 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.0 |
0.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:0006293 |
nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.0 |
0.0 |
GO:1903464 |
negative regulation of mitotic cell cycle DNA replication(GO:1903464) |
| 0.0 |
0.1 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
0.0 |
GO:0097477 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.0 |
0.0 |
GO:0070103 |
regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.0 |
0.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.0 |
0.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.0 |
0.0 |
GO:0010446 |
response to alkaline pH(GO:0010446) |
| 0.0 |
0.0 |
GO:0050923 |
regulation of negative chemotaxis(GO:0050923) |
| 0.0 |
0.0 |
GO:0003149 |
membranous septum morphogenesis(GO:0003149) |
| 0.0 |
0.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.3 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.0 |
0.2 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.1 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.0 |
0.0 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.0 |
0.3 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.0 |
0.2 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.0 |
0.0 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 |
0.0 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 |
0.0 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.0 |
0.2 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.0 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.0 |
0.0 |
GO:0001547 |
antral ovarian follicle growth(GO:0001547) |
| 0.0 |
0.1 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.0 |
0.0 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.0 |
0.0 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 0.0 |
0.4 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.0 |
0.0 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.0 |
0.0 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.0 |
0.1 |
GO:0050686 |
negative regulation of mRNA processing(GO:0050686) |
| 0.0 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.0 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.0 |
0.1 |
GO:0060746 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 |
0.0 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.0 |
0.0 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.2 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.2 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.1 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.0 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.1 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.0 |
0.0 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 |
0.1 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.2 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.1 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 |
0.1 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.0 |
0.1 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.1 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.0 |
0.1 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
0.0 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.0 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.0 |
0.0 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.0 |
0.0 |
GO:0006522 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 |
0.0 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 0.0 |
0.0 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.0 |
0.6 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.0 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.0 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
